BRANFORD, Conn. – June 25, 2006 – 454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation (Nasdaq: CRGN), in collaboration with scientists at Dana Farber Cancer Center and ...
454 Life Sciences has announced the publication of over 100 peer-reviewed studies using the Company's Genome Sequencer System. The studies span a diverse group of DNA sequencing applications, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results